Summary
Latest filing:
David C. Mun-Gavin is Director of GT Biopharma, Inc. (GTBP). 1 SEC Form 4 filing on record, dated 4 September 2025.
Trading Pattern
InsiderAlpha's records for David C. Mun-Gavin go back to 2025: 1 primary Form 4 filing, an average of 0.5 per year. No recorded transaction carries a Rule 10b5-1 plan flag. An absent flag does not establish whether a transaction was pre-arranged or discretionary.
Other Insiders Active in the Same Sector
No other insider has filed at David C. Mun-Gavin's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- AI DMI LLC - $59.87M of IRON open-market activity in the last 12 months
- RA CAPITAL MANAGEMENT, L.P. - $59.04M of SGP open-market activity in the last 12 months
- John E. Kao - $57.28M of ALHC open-market activity in the last 12 months
- ORBIMED ADVISORS LLC - $55.67M of SION open-market activity in the last 12 months
- Peter A. Thompson - $55.67M of SION open-market activity in the last 12 months
- Mark A. Goldsmith - $54.20M of RVMD open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is David C. Mun-Gavin?
David C. Mun-Gavin is a corporate insider, tracked as Director of GT Biopharma, Inc. (GTBP). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did David C. Mun-Gavin last file a Form 4?
The only primary Form 4 on record is dated 4 September 2025.
Where can I see all of David C. Mun-Gavin's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow David C. Mun-Gavin and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial